Abstract
Much of the fascination of the Wilms tumor protein (WT1) emanates from its unique roles in development and disease. Ubiquitous Wt1 deletion in adult mice causes multiple organ failure including a reduction of body fat. WT1 is expressed in fat cell progenitors in visceral white adipose tissue (WAT) but detected neither in energy storing subcutaneous WAT nor in heat producing brown adipose tissue (BAT). Our recent findings indicate that WT1 represses thermogenic genes and maintains the white adipose identity of visceral fat. Wt1 heterozygosity in mice is associated with molecular and morphological signs of browning including elevated levels of uncoupling protein 1 (UCP1) in epididymal WAT. Compared to their wild-type littermates, Wt1 heterozygous mice exhibit significantly improved whole-body glucose tolerance and alleviated hepatic steatosis under high-fat diet. Partial protection of heterozygous Wt1 knockout mice against metabolic dysfunction is presumably related to browning of their epididymal WAT. In the light of recent advancements, this article reviews the role of WT1 in the development of visceral WAT and its supposed function as a regulator of white adipose identity.
Introduction
Since the initial discovery that mice with homozygous disruption of the Wilms tumor gene 1 (Wt1) are embryonic lethal with a failure of kidney and gonad formation (Kreidberg et al., 1993), the knowledge of the role of the WT1 in development has steadily increased. (Hastie, 2017). It is now well documented that the importance of WT1 during embryogenesis extends far beyond the genitourinary system and also includes the mesothelium (Kreidberg et al., 1993; Moore et al., 1999), spleen (Herzer et al., 1999), adrenal gland (Moore et al., 1999), hematopoietic (Alberta et al., 2003) and nervous system. (Wagner et al., 2002; Wagner et al., 2005). The WT1 gene encodes a zinc finger protein with more than 30 mammalian isoforms resulting from the use of variant transcriptional and translational start sites, alternative pre-mRNA splicing and RNA editing. (Hastie, 2017). Non-mammalian vertebrates have only two WT1 isoforms, which differ by the insertion/exclusion of three amino acids, lysine, threonine and serine (KTS), between zinc fingers three and four. (Haber et al., 1991). WT1 (-KTS) molecules without the KTS tripeptide insertion function as transcription factors, and much knowledge about the role of WT1 in development and disease has been obtained from the identification of downstream target genes. (Toska and Roberts, 2014; Hastie, 2017). By interacting with other protein binding partners, WT1 is converted from an activator to a repressor of transcription. (Carpenter et al., 2004; Toska and Roberts, 2014). Compared to the WT1 (-KTS) variants, WT1 isoforms harboring the tripeptide insertion in their zinc finger domain have a higher RNA binding affinity and may operate predominantly through post-transcriptional mechanisms. (Larsson et al., 1995; Niksic et al., 2004; Bor et al., 2006). In addition, WT1 has been shown to regulate chromatin switching between an active and repressed configuration at the Wnt4 locus. (Essafi et al., 2011). Recent findings indicate that WT1 is also involved in the epigenetic control of gene expression. (Rampal et al., 2014; Wang et al., 2015). A unifying concept of the biological processes that are regulated by WT1 in different tissues has not evolved yet. However, insights gained from Wt1 knockout mice and target gene identification suggest that WT1 controls the reciprocal switch between a mesenchymal and epithelial cellular state. (Hohenstein and Hastie, 2006). In tissues undergoing epithelial differentiation during development, e.g. kidneys and gonads, WT1 promotes mesenchymal-to-epithelial transition (MET). (Davies et al., 2004; Essafi et al., 2011). In other tissues, such as embryonic heart and diaphragm, WT1 is necessary for the reverse process, i.e. epithelial-to-mesenchymal transition (EMT). (Martínez-Estrada et al., 2010; Hastie, 2017). This mini-review is focused on the role of WT1 in the development and maintenance of adipose tissue.
The main function of visceral (intra-abdominal) and subcutaneous white adipose tissue (WAT) is energy storage in the form of triglycerides. Interscapular brown adipose tissue (BAT) powers energy expenditure by non-shivering thermogenesis. The latter process requires uncoupling protein-1 (UCP1), a pore-forming molecule in the inner mitochondrial membrane of brown adipocytes that dissociates H+-fluxes from ATP synthesis. (Chouchani et al., 2019; Ikeda and Yamada, 2020; Bertholet and Kirichok, 2021). Marked differences exist between visceral and subcutaneous WAT. While intra-abdominal obesity correlates with increased mortality, subcutaneous WAT is considered as being protective. (Wajchenberg, 2000; Pischon et al., 2008; Manolopoulos et al., 2010). Unlike subcutaneous fat deposition, visceral obesity is associated with chronic diseases including type 2 diabetes, atherosclerosis and cancer. (Stefan, 2020). Intra-abdominal fat accumulation also has a chronic inflammatory component with elevated serum levels of cytokines, which may contribute to impaired metabolism in obesity. (Silveira Rossi et al., 2021). It is still a matter of debate whether adipose tissue inflammation is cause or consequence of insulin resistance. (Burhans et al., 2018; Shimobayashi et al., 2018). In general, subcutaneous WAT is more sensitive to insulin than visceral WAT, and intra-abdominal obesity correlates with insulin resistance. (Longo et al., 2019). Several conditions may account for the detrimental effect of intra-abdominal fat accumulation. The “portal vein theory” proposes that free fatty acids and cytokines released from visceral WAT are directly transported to the liver, where they might cause organ damage. This hypothesis is supported by data showing that transplanted epididymal fat pads cause impaired glucose tolerance and hepatic insulin resistance in recipient mice only when they drain into the portal ciruculation. (Rytka et al., 2011). Due to its anatomical localization, visceral WAT is exposed to potentially harmful gut microbiota-derived products. (Geurts et al., 2014; Hersoug et al., 2016). Among those, reabsorption of bacterial lipopolysaccharides (LPS) across the intestinal mucosa and subsequent uptake from the circulation by adipocytes can promote a local inflammatory response. (Hersoug et al., 2016). Furthermore, intrinsic differences may exist between subcutaneous and visceral WAT depots. This view is supported by transplantation experiments demonstrating that subcutaneous but not visceral adipose tissue reduces body weight, blood glucose and insulin levels in grafted mice. (Tran et al., 2008). Moreover, single-cell RNA sequencing identified a class of adipocyte progenitors that are unique to visceral adipose tissue (Vijay et al., 2020), and developmental and functional heterogeneities of (pre)adipocytes may exist even within a single WAT depot. (Hwang and Kim, 2019; Lee et al., 2019; Vishvanath and Gupta, 2019).
Visceral and subcutaneous WAT also differ in their browning capacity. Browning describes the phenomenon that classical thermogenic genes, e.g. UCP1, PRDM16 and PPARGC1A, are switched-on in WAT upon exposure to appropriate stimuli such as prolonged cold exposure and treatment with β3-adrenergic agonists. (Herz and Kiefer, 2019; Moreno-Navarrete and Fernandez-Real, 2019; Van Nguyen et al., 2020; Mu et al., 2021). It is currently unclear whether WAT browning is due to the recruitment of beige/brite (brown-in-white) adipocytes capable of thermogenic gene expression from a distinct population of progenitor cells and/or the interconversion of mature white to beige adipocytes. (Barbatelli et al., 2010; Lee et al., 2012). Ultimately, which one of the two routes is taken to generate beige adipocytes in WAT may depend on multiple conditions including the intensity of the underlying stimulus, environmental factors, the genetic background and epigenetic mechanisms. (Herz and Kiefer, 2019) The browning capacity varies considerably between different WAT depots. Thermogenic genes in mice can be induced more readily in subcutaneous than visceral WAT. (Vitali et al., 2012; Jia et al., 2016) While it is still a matter of controversy whether this is valid also for humans (Sidossis et al., 2015; Zuriaga et al., 2017), WAT browning has gained considerable interest for its potential use to tackle obesity and metabolic disease. (Cheng et al., 2021; Wang and Wei, 2021).
WT1 is Required for the Development and Maintenance of Visceral Fat Depots
Chau et al. were the first showing that the physiological significance of WT1 is not restricted to embryogenesis but spans the entire lifetime. (Chau et al., 2011). They used a tamoxifen-inducible transgenic approach to demonstrate that ubiquitous Wt1 deletion in mature mice causes acute multiple organ failure including glomerular kidney injury, atrophy of the exocrine pancreas and impaired erythropoiesis. (Chau et al., 2011). Surprisingly, WT1-depleted adult mice also exhibit a strongly reduced bone and fat mass, both tissues sharing their origin from common mesenchymal stem cells. (Chau et al., 2011; Favaretto et al., 2021). Fat loss in mice with induced Wt1 knockout affects both, the intra-abdominal WAT and the interscapular BAT. (Chau et al., 2011). A recent study confirmed the reduction of mesenteric fat in WT1 depleted adult mice. (Wilm et al., 2021). Lineage tracing experiments in mice endorse the contribution of mesothelium-derived Wt1 expressing cells to all visceral WAT depots. (Chau et al., 2014). Wt1 expressing cells do not contribute to the BAT lineage, which originates from Myf5+ cells in the paraxial mesoderm nor to subcutaneous WAT, whose developmental origin is not well understood. (Chau et al., 2014). Hence, the reduction of BAT mass in adult mice with induced Wt1 deletion does not reflect a cell autonomous defect of brown (pre)adipocytes, but is possibly related to the suppressed IGF-1 serum levels of these animals. (Chau et al., 2011). This assumption, which has not been proven yet, is supported by the atrophy of BAT following conditional deletion of the IGF-1 receptor in mouse adipose tissues (Boucher et al., 2016).
In all visceral WAT depots, WT1 can be detected in the stromal vascular fraction (SVF) containing the fat cell progenitors (preadipocytes), endothelial and immune cells. Wt1 is not expressed in mature adipocytes. (Chau et al., 2014). Importantly, the contribution of Wt1 expressing cells to visceral WAT is not terminated at the end of gestation, but a subset of fat appendages, particularly in the epididymal region, continue to arise from WT1-positive progenitor cells postnatally. (Chau et al., 2014). It is tempting to speculate, whether WT1 determines the fate of a subpopulation of progenitor cells in visceral WAT. (Chau and Hastie, 2015). This idea is corroborated by the observation that adipocytes derived from WT1-positve vs. WT1-negative progenitor cells differ in their size and lipid droplet distribution. (Chau et al., 2014). Furthermore, microarray hybridization experiments identify WT1 as one out of only three transcription factors showing a visceral fat-selective expression profile in mice. (Cohen et al., 2014).
WT1-positive SVF cells can be induced to differentiate in vitro not only to adipocytes but also to muscle cells and–to a lesser extent–osteoblasts. (Chau et al., 2014). The osteoblast forming capacity differs among visceral WAT depots suggesting functional heterogeneity even within the subpopulation of WT1-positive prognitors. (Chau et al., 2014) A recent lineage tracing study by Wilm et al. shows that Wt1 expressing mesothelial cells in adult peritoneum do not contribute to the deeper stromal and parenchymal compartments in the abdominal cavity, but rather constitute the progenitor niche for visceral WAT. (Wilm et al., 2021) It is well documented that adult mesothelial cells can undergo epithelial-to-mesenchymal transition (EMT) under challenging conditions such as peritoneal injury. (Han et al., 2019; Lho et al., 2021) Considering the established role of WT1 in EMT (Martínez-Estrada et al., 2010; Essafi et al., 2011; Hastie, 2017), one can hypothesize whether WT1 enables progenitor cells in the mesothelium to acquire a mesenchymal phenotype and provide a pool of adipocyte progenitors. However, the developmental origin of visceral fat from mesothelium has been challenged by a recent study. Using single-cell RNA sequencing, Westcott et al. show that WT1 is not restricted to visceral adipose mesothelium but also expressed in a population of Pdgfra+ and Sca-1+ preadipocytes in mice and humans. (Westcott et al., 2021). These authors identify keratin 19 (Krt19) as a highly specific marker for adult mouse mesothelium and demonstrate that Krt19+ cells do not differentiate to adipocytes in vitro, nor do they contribute to the pool of adipocytes in visceral fat depots in vivo. (Westcott et al., 2021). Furthermore, studies incorporating single-cell RNA sequencing in murine visceral WAT detected Wt1 in non-mesothelial stromal cell polulations. (Burl et al., 2018; Hepler et al., 2018). According to these data, Wt1 expressing preadipocytes are distinct from Wt1 expressing mesothelial cells.
WT1 Represses Thermogenic Genes
Recent studies demonstrate that WT1 represses a classical BAT genetic signature in visceral WAT. Thus, SVF cells isolated from visceral WAT of transgenic mice with adipocyte-specific deletion of Wt1 express thermogenic genes including Ucp1, Prdm16 and Cidea. (Cohen et al., 2014) PRDM16 is a transcriptional co-regulator that controls the developmental switch between skeletal muscle myoblasts and brown adipocytes from common Myf5+ progenitors. (Seale et al., 2008). Prdm16 is highly expressed in the interscapular BAT and significantly elevated in subcutaneous compared to visceral fat depots. (Cohen et al., 2014). Adipocyte-selective deletion of the Prdm16 gene in mice abrogates thermogenic gene expression in beige adipocytes, while leaving the function of classical BAT intact. (Cohen et al., 2014). When kept on high-fat diet, mice lacking PRDM16 in their adipocytes acquire a phenotype of visceral obesity with insulin resistance, hepatic steatosis and subcutaneous macrophage infiltration. (Cohen et al., 2014). Conversely, transgenic overexpression of Prdm16 driven by the aP2-promoter in adipose tissues gives rise to beige adipocytes in subcutaneous but not in epididymal WAT. (Seale et al., 2011). Hence, it is unlikely that the lower levels of endogenous PRDM16 account for the poorer browning susceptibility of visceral vs. subcutaneous WAT. Instead, yet unknown factors may exist in visceral WAT that confer resistance to browning stimuli, and WT1 might be one of those. The successive decline of Prdm16 transcripts in differentiating primary preadipocytes was associated with increasing levels of Wt1 mRNA suggesting that the browning inducer PRDM16 and WT1 are reciprocally regulated. (Cohen et al., 2014). It would be worthwhile to investigate in future studies whether PRDM16 functions as a direct inhibitor of Wt1 expression during adipocyte differentiation.
In the light of the above, we reasoned that WT1 might prevent a thermogenic gene expression program in visceral WAT. We addressed this issue by combining in vitro differentiation of brown preadipocytes with in vivo analyses of WAT depots in wild-type and heterozygous Wt1 knockout mice. Retroviral delivery of WT1 repressed thermogenic genes upon in vitro differentiation of immortalized brown preadipocytes. (Kirschner et al., 2022). Likewise, overexpression of Wt1 reduced Ucp1, Ppargc1a, Cidea, Prdm16 and Cpt1b transcripts in differentiating Sca1+:CD45−:CD31− preadipocytes isolated from the interscapular BAT of mice. (Kirschner et al., 2022). WT1 caused no changes of adipocyte-selective genes that are expressed in both, white and brown fat cells. WT1 also did not interfere with overall adipogenic differentiation assessed in terms of intracellular lipid storage. (Kirschner et al., 2022). These findings let us conclude that ectopic WT1 suppresses the genetic signature of brown adipocytes. This idea is strengthened by the observation that adipocytes arising from WT1-positive progenitors in epididymal WAT contain fewer but larger lipid droplets in their cytoplasm (Figure 1). (Chau et al., 2014)
FIGURE 1
To identify potential WT1 target genes, we silenced endogenous Wt1 in murine epididymal SVF cells by RNA interference. Knockdown of Wt1 reduced Aldh1a1 and Zfp423 transcripts in these cells. On the other hand, both RNAs increased significantly upon forced expression of WT1 in brown preadipoytes. (Kirschner et al., 2022). Targeted inactivation of Aldh1a1 and Zfp423 has been reported to induce thermogenic genes in WAT of mice. (Kiefer et al., 2012; Shao et al., 2016; Hepler et al., 2017). ALDH1A1 catalyzes the oxidation of retinaldehyde (Rald) to retinoic acid, and Aldh1a1 deficiency causes accumulation of Rald in WAT. (Ziouzenkova et al., 2007; Molotkov and Duester, 2003). Rald stimulates the expression of Ucp1 and other thermogenic genes in white fat cells by activating the retinoic acid receptor (RAR) (Figure 2). (Kiefer et al., 2012) The transcription factor ZFP423 represses thermogenic genes by inhibiting the activity of the transcriptional co-regulator EBF2. Mechanistically, ZFP423 recruits the NuRD co-repressor complex that prevents EBF2 from activating thermogenic genes (Figure 2). (Shao et al., 2021) Disruption of the ZFP423-EBF2 protein interaction induces a shift in PPARγ occupancy of thermogenic genes and elicits widespread WAT browning in adult mice (Figure 2). (Shao et al., 2016; Shao et al., 2021) ChIP-sequencing analysis of genomic WT1 binding sites in mouse embryonic kidneys classify Zfp423 among the top 1,000 genes (p-value 4.7 × 10–23). (Motamedi et al., 2014). These data suggest that WT1 stimulates Aldh1a1 and Zfp423 expression in epididymal SVF cells either directly or through indirect mechanisms. By increasing ALDH1 and ZFP423 levels, WT1 presumably represses a genetic program of classical BAT in white preadipocytes. Notably, inactivation of Aldh1a1 and Zfp423 in mice causes WAT browning not only in intra-abdominal but also in subcutaneous fat depots indicating that these molecules do not convey a specific action of WT1 in visceral WAT. (Kiefer et al., 2012; Shao et al., 2016; Shao et al., 2021). Genome-wide approaches combining RNA deep sequencing with ChIP sequencing technology might give a more complete picture of the transcriptional events that are regulated by WT1 in visceral fat cell progenitors.
FIGURE 2
Heterozygous Wt1 Knockout Mice Show Improved Glucose and Lipid Metabolism
Using mice with a heterozygous Wt1 gene, we next examined whether WT1 inhibits thermogenic gene expression also in visceral WAT in vivo. Unlike the embryonic lethal full knockout, Wt1 heterozygous mice are viable and lack obvious developmental abnormalities. (Kreidberg et al., 1993). Strikingly, Wt1 heterozygosity is associated with molecular and morphological signs of browning including elevated UCP1 levels in epididymal WAT (Figure 1). (Kirschner et al., 2022) No differences in thermogenic gene expression in interscapular BAT and subcutaneous WAT, i.e. in WT1-negative fat depots, are detectable between wild-type and heterozygous Wt1 knockout mice. (Kirschner et al., 2022). These findings suggest that WT1 is necessary for maintaining a white adipose identity in epididymal WAT. Notably, β3-adrenergic stimulation increases thermogenic gene expression to a similar extent in wild-type and heterozygous Wt1 knockout mice suggesting that WT1 does not limit the overall browning capacity of epididymal WAT. (Kirschner et al., 2022).
Inhibition of beige fat cell function by adipocyte-specific deletion of Prdm16 in mice causes severe metabolic disorder with insulin resistance and diet-induced fatty liver disease. (Cohen et al., 2014). This observation prompted us to examine whether differences in glucose and lipid metabolism exist between wild-type and heterozygous Wt1 knockout mice. Compared with their wild-type littermates, Wt1 mutant mice exhibit significantly improved whole-body glucose tolerance and much weaker hepatic steatosis when kept on a high-fat diet for 11 weeks. (Kirschner et al., 2022). Superior metabolic function is observed also in other genetic mouse models of enhanced WAT browning including deletion of Ago1 in vascular endothelial cells (Tang et al., 2020), ROCK2 depletion (Wei et al., 2020), and adipose-specific knockout of Hoxc10. (Tan et al., 2021). We therefore assume that improved metabolic health of heterozygous Wt1 knockout mice is related to the activation of a thermogenic program in their visceral WAT. However, other cell types and tissues might be involved as well. Notably, Wt1 expressing cells delaminating from the coelomic epithelium contribute to the pool of stellate cell progenitors in mouse liver. (Ijpenberg et al., 2007). Hepatic stellate cells are the major storage site of retinyl esters in the body. (Haaker et al., 2020). Following hepatic injury, retinol is released from these cells and partially converted to retinoic acid (RA) by the enzymatic activity of retinaldehyde dehydrogenases (RALDH). (Haaker et al., 2020). Interestingly, Aldh1a2, the predominant isoform that encodes RALDH2 in embryonic tissues, is a direct downstream target gene of WT1 in developing epicardial cells. (Guadix et al., 2011). Retinoid signaling is important for normal liver function, and serum levels of retinol and RA are reduced in non-alcoholic fatty liver disease. (Saeed et al., 2017). Mice heterozygous for Rdh10, a gene encoding retinol dehydrogenase, develop glucose intolerance and severe hepatic steatosis under high-fat diet. Their phenotype can be rescued by treatment with all-trans RA. (Yang et al., 2019). These data raise the possibility that impaired retinoid signaling of hepatic stellate cells contributes to the metabolic abnormalities of heterozygous Wt1 knockout mice. The generation of transgenic mouse lines with conditional Wt1 deletion in progenitor cells of visceral WAT and hepatic stellate cells can shed some light onto this issue.
Conclusion, Perspectives and Open Questions
Visceral WAT is a prime example for the complex role of WT1 reaching from embryogenesis to adulthood. Recent data suggest that WT1 is necessary for maintaining white adipose identity in visceral WAT. (Kirschner et al., 2022). Further studies including genome-wide single cell sequencing technologies may help to identify WT1 downstream target genes and elucidate the molecular mechanisms by which WT1 represses browning processes in visceral WAT. Strikingly, glucose and fat metabolism are better preserved in Wt1 heterozygous than in wild-type mice under high-fat diet. (Kirschner et al., 2022). Circumstantial evidence suggests that improved metabolic function of heterozygous Wt1 knockout mice is due to the expression of Ucp1 and other thermogenic genes in their visceral WAT, a phenomenon referred to as browning. This hypothesis needs to be proven by generating and characterizing mouse lines with selective deletion of Wt1 in white preadipocytes. These transgenic mice might also be useful for identifying WT1-dependent transcriptional networks in fat cell development. Another important issue is to clarify whether WT1 determines the white adipocyte fate also in visceral WAT in humans. If so, this could fuel further studies aiming to establish WT1 as a potential therapeutic target in metabolic disorders.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Funding
All sources of funding received for the research being submitted. The authors’ work referred to in this article was supported by grants from the Else Kröner-Fresenius-Stiftung (Grant 2014_A23) and the Deutsche Diabetes Stiftung (Grant FP-0403-2017). The authors acknowledge the financial support of their work by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) ‐ Project-ID 394046635 ‐ SFB 1365 Renoprotection.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AlbertaJ. A.SpringettG. M.RayburnH.NatoliT. A.LoringJ.KreidbergJ. A.et al (2003). Role of the WT1 Tumor Suppressor in Murine Hematopoiesis. Blood101 (7), 2570–2574. 10.1182/blood-2002-06-1656
2
BarbatelliG.MuranoI.MadsenL.HaoQ.JimenezM.KristiansenK.et al (2010). The Emergence of Cold-Induced Brown Adipocytes in Mouse white Fat Depots Is Determined Predominantly by white to Brown Adipocyte Transdifferentiation. Am. J. Physiology-Endocrinology Metab.298 (6), E1244–E1253. 10.1152/ajpendo.00600.2009
3
BertholetA. M.KirichokY. (2021). Mitochondrial H(+) Leak and Thermogenesis. Annu. Rev. Physiol.84, 381. 10.1146/annurev-physiol-021119-034405
4
BorY.SwartzJ.MorrisonA.RekoshD.LadomeryM.HammarskjöldM.-L. (2006). The Wilms' Tumor 1 (WT1) Gene (+KTS Isoform) Functions with a CTE to Enhance Translation from an Unspliced RNA with a Retained Intron. Genes Dev.20 (12), 1597–1608. 10.1101/gad.1402306
5
BoucherJ.SofticS.El OuaamariA.KrumpochM. T.KleinriddersA.KulkarniR. N.et al (2016). Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function. Diabetes65 (8), 2201–2213. 10.2337/db16-0212
6
BurhansM. S.HagmanD. K.KuzmaJ. N.SchmidtK. A.KratzM. (2018). Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr. Physiol.9 (1), 1–58. 10.1002/cphy.c170040
7
BurlR. B.RamseyerV. D.RondiniE. A.Pique-RegiR.LeeY.-H.GrannemanJ. G. (2018). Deconstructing Adipogenesis Induced by β3-Adrenergic Receptor Activation with Single-Cell Expression Profiling. Cel Metab.28 (2), 300–309. 10.1016/j.cmet.2018.05.025
8
CarpenterB.HillK. J.CharalambousM.WagnerK. J.LahiriD.JamesD. I.et al (2004). BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1. Mol. Cel Biol24 (2), 537–549. 10.1128/mcb.24.2.537-549.2004
9
ChauY.-Y.BandieraR.SerrelsA.Martínez-EstradaO. M.QingW.LeeM.et al (2014). Visceral and Subcutaneous Fat Have Different Origins and Evidence Supports a Mesothelial Source. Nat. Cel Biol16 (4), 367–375. 10.1038/ncb2922
10
ChauY.-Y.BrownsteinD.MjosengH.LeeW.-C.Buza-VidasN.NerlovC.et al (2011). Acute Multiple Organ Failure in Adult Mice Deleted for the Developmental Regulator Wt1. Plos Genet.7 (12), e1002404. 10.1371/journal.pgen.1002404
11
ChauY.-Y.HastieN. (2015). Wt1, the Mesothelium and the Origins and Heterogeneity of Visceral Fat Progenitors. Adipocyte4 (3), 217–221. 10.4161/21623945.2014.985009
12
ChengL.WangJ.DaiH.DuanY.AnY.ShiL.et al (2021). Brown and Beige Adipose Tissue: a Novel Therapeutic Strategy for Obesity and Type 2 Diabetes Mellitus. Adipocyte10 (1), 48–65. 10.1080/21623945.2020.1870060
13
ChouchaniE. T.KazakL.SpiegelmanB. M. (2019). New Advances in Adaptive Thermogenesis: UCP1 and beyond. Cel Metab.29 (1), 27–37. 10.1016/j.cmet.2018.11.002
14
CohenP.LevyJ. D.ZhangY.FrontiniA.KolodinD. P.SvenssonK. J.et al (2014). Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch. Cell156 (1-2), 304–316. 10.1016/j.cell.2013.12.021
15
DaviesJ. A.LadomeryM.HohensteinP.MichaelL.ShafeA.SpraggonL.et al (2004). Development of an siRNA-Based Method for Repressing Specific Genes in Renal Organ Culture and its Use to Show that the Wt1 Tumour Suppressor Is Required for Nephron Differentiation. Hum. Mol. Genet.13 (2), 235–246. 10.1093/hmg/ddh015
16
EssafiA.WebbA.BerryR. L.SlightJ.BurnS. F.SpraggonL.et al (2011). A Wt1-Controlled Chromatin Switching Mechanism Underpins Tissue-specific Wnt4 Activation and Repression. Dev. Cel21 (3), 559–574. 10.1016/j.devcel.2011.07.014
17
FavarettoF.BettiniS.BusettoL.MilanG.VettorR. (2021). Adipogenic Progenitors in Different Organs: Pathophysiological Implications. Rev. Endocr. Metab. Disord.23, 71. 10.1007/s11154-021-09686-6
18
GeurtsL.NeyrinckA. M.DelzenneN. M.KnaufC.CaniP. D. (2014). Gut Microbiota Controls Adipose Tissue Expansion, Gut Barrier and Glucose Metabolism: Novel Insights into Molecular Targets and Interventions Using Prebiotics. Beneficial Microbes5 (1), 3–17. 10.3920/bm2012.0065
19
GuadixJ. A.Ruiz-VillalbaA.LetticeL.VelecelaV.Muñoz-ChápuliR.HastieN. D.et al (2011). Wt1 Controls Retinoic Acid Signalling in Embryonic Epicardium through Transcriptional Activation of Raldh2. Development138 (6), 1093–1097. 10.1242/dev.044594
20
HaakerM. W.VaandragerA. B.HelmsJ. B. (2020). Retinoids in Health and Disease: A Role for Hepatic Stellate Cells in Affecting Retinoid Levels. Biochim. Biophys. Acta (Bba) - Mol. Cel Biol. Lipids1865 (6), 158674. 10.1016/j.bbalip.2020.158674
21
HaberD. A.SohnR. L.BucklerA. J.PelletierJ.CallK. M.HousmanD. E. (1991). Alternative Splicing and Genomic Structure of the Wilms Tumor Gene WT1. Proc. Natl. Acad. Sci.88 (21), 9618–9622. 10.1073/pnas.88.21.9618
22
HanS. M.RyuH.-M.SuhJ.LeeK.-J.ChoiS.-Y.ChoiS.et al (2019). Network-based Integrated Analysis of Omics Data Reveal Novel Players of TGF-Β1-Induced EMT in Human Peritoneal Mesothelial Cells. Sci. Rep.9 (1), 1497. 10.1038/s41598-018-37101-9
23
HastieN. D. (2017). Wilms' Tumour 1 (WT1) in Development, Homeostasis and Disease. Development144 (16), 2862–2872. 10.1242/dev.153163
24
HeplerC.ShanB.ZhangQ.HenryG. H.ShaoM.VishvanathL.et al (2018). Identification of Functionally Distinct Fibro-Inflammatory and Adipogenic Stromal Subpopulations in Visceral Adipose Tissue of Adult Mice. Elife7, e39636. 10.7554/eLife.39636
25
HeplerC.ShaoM.XiaJ. Y.GhabenA. L.PearsonM. J.VishvanathL.et al (2017). Directing Visceral white Adipocyte Precursors to a Thermogenic Adipocyte Fate Improves Insulin Sensitivity in Obese Mice. Elife6, e27669. 10.7554/eLife.27669
26
HersougL.-G.MøllerP.LoftS. (2016). Gut Microbiota-Derived Lipopolysaccharide Uptake and Trafficking to Adipose Tissue: Implications for Inflammation and Obesity. Obes. Rev.17 (4), 297–312. 10.1111/obr.12370
27
HerzC. T.KieferF. W. (2019). Adipose Tissue browning in Mice and Humans. J. Endocrinol.241 (3), R97–r109. 10.1530/joe-18-0598
28
HerzerU.CrocollA.BartonD.HowellsN.EnglertC. (1999). The Wilms Tumor Suppressor Gene Wt1 Is Required for Development of the Spleen. Curr. Biol.9 (15), 837–S1. 10.1016/s0960-9822(99)80369-8
29
HohensteinP.HastieN. D. (2006). The many Facets of the Wilms' Tumour Gene, WT1. Hum. Mol. Genet.15 Spec No 2 (2), R196–R201. 10.1093/hmg/ddl196 No
30
HwangI.KimJ. B. (2019). Two Faces of White Adipose Tissue with Heterogeneous Adipogenic Progenitors. Diabetes Metab. J.43 (6), 752–762. 10.4093/dmj.2019.0174
31
IjpenbergA.Pérez-PomaresJ. M.GuadixJ. A.CarmonaR.Portillo-SánchezV.MacíasD.et al (2007). Wt1 and Retinoic Acid Signaling Are Essential for Stellate Cell Development and Liver Morphogenesis. Dev. Biol.312 (1), 157–170. 10.1016/j.ydbio.2007.09.014
32
IkedaK.YamadaT. (2020). UCP1 Dependent and Independent Thermogenesis in Brown and Beige Adipocytes. Front. Endocrinol.11, 498. 10.3389/fendo.2020.00498
33
JiaR.LuoX.-Q.WangG.LinC.-X.QiaoH.WangN.et al (2016). Characterization of Cold-Induced Remodelling Reveals Depot-specific Differences across and within Brown and white Adipose Tissues in Mice. Acta Physiol.217 (4), 311–324. 10.1111/apha.12688
34
KieferF. W.VernochetC.O'BrienP.SpoerlS.BrownJ. D.NallamshettyS.et al (2012). Retinaldehyde Dehydrogenase 1 Regulates a Thermogenic Program in white Adipose Tissue. Nat. Med.18 (6), 918–925. 10.1038/nm.2757
35
KirschnerK. M.Foryst-LudwigA.GohlkeS.LiC.FloresR. E.KintscherU.et al (2022). Wt1 Haploinsufficiency Induces browning of Epididymal Fat and Alleviates Metabolic Dysfunction in Mice on High-Fat Diet. Diabetologia65 (3), 528–540. 10.1007/s00125-021-05621-1
36
KreidbergJ. A.SariolaH.LoringJ. M.MaedaM.PelletierJ.HousmanD.et al (1993). WT-1 Is Required for Early Kidney Development. Cell74 (4), 679–691. 10.1016/0092-8674(93)90515-r
37
LarssonS. H.CharlieuJ.-P.MiyagawaK.EngelkampD.RassoulzadeganM.RossA.et al (1995). Subnuclear Localization of WT1 in Splicing or Transcription Factor Domains Is Regulated by Alternative Splicing. Cell81 (3), 391–401. 10.1016/0092-8674(95)90392-5
38
LeeK. Y.LuongQ.SharmaR.DreyfussJ. M.UssarS.KahnC. R. (2019). Developmental and Functional Heterogeneity of white Adipocytes within a Single Fat Depot. Embo j38 (3), e99291. 10.15252/embj.201899291
39
LeeY.-H.PetkovaA. P.MottilloE. P.GrannemanJ. G. (2012). In Vivo Identification of Bipotential Adipocyte Progenitors Recruited by β3-Adrenoceptor Activation and High-Fat Feeding. Cel Metab.15 (4), 480–491. 10.1016/j.cmet.2012.03.009
40
LhoY.DoJ. Y.HeoJ. Y.KimA. Y.KimS. W.KangS. H. (2021). Effects of TGF-Β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells. Int. J. Mol. Sci.22 (9). 10.3390/ijms22094739
41
LongoM.ZatteraleF.NaderiJ.ParrilloL.FormisanoP.RacitiG. A.et al (2019). Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int. J. Mol. Sci.20 (9), 2358. 10.3390/ijms20092358
42
ManolopoulosK. N.KarpeF.FraynK. N. (2010). Gluteofemoral Body Fat as a Determinant of Metabolic Health. Int. J. Obes.34 (6), 949–959. 10.1038/ijo.2009.286
43
Martínez-EstradaO. M.LetticeL. A.EssafiA.GuadixJ. A.SlightJ.VelecelaV.et al (2010). Wt1 Is Required for Cardiovascular Progenitor Cell Formation through Transcriptional Control of Snail and E-Cadherin. Nat. Genet.42 (1), 89–93. 10.1038/ng.494
44
MolotkovA.DuesterG. (2003). Genetic Evidence that Retinaldehyde Dehydrogenase Raldh1 (Aldh1a1) Functions Downstream of Alcohol Dehydrogenase Adh1 in Metabolism of Retinol to Retinoic Acid. J. Biol. Chem.278 (38), 36085–36090. 10.1074/jbc.m303709200
45
MooreA. W.McInnesL.KreidbergJ.HastieN. D.SchedlA. (1999). YAC Complementation Shows a Requirement for Wt1 in the Development of Epicardium, Adrenal Gland and throughout Nephrogenesis. Development126 (9), 1845–1857. 10.1242/dev.126.9.1845
46
Moreno-NavarreteJ. M.Fernandez-RealJ. M. (2019). The Gut Microbiota Modulates Both browning of white Adipose Tissue and the Activity of Brown Adipose Tissue. Rev. Endocr. Metab. Disord.20 (4), 387–397. 10.1007/s11154-019-09523-x
47
MotamediF. J.BadroD. A.ClarksonM.Rita LeccaM.BradfordS. T.BuskeF. A.et al (2014). WT1 Controls Antagonistic FGF and BMP-pSMAD Pathways in Early Renal Progenitors. Nat. Commun.5, 4444. 10.1038/ncomms5444
48
MuW. J.ZhuJ. Y.ChenM.GuoL. (2021). Exercise-Mediated Browning of White Adipose Tissue: Its Significance, Mechanism and Effectiveness. Int. J. Mol. Sci.22 (21), 11512. 10.3390/ijms222111512
49
NiksicM.SlightJ.SanfordJ. R.CaceresJ. F.HastieN. D. (2004). The Wilms' Tumour Protein (WT1) Shuttles between Nucleus and Cytoplasm and Is Present in Functional Polysomes. Hum. Mol. Genet.13 (4), 463–471. 10.1093/hmg/ddh040
50
PischonT.BoeingH.HoffmannK.BergmannM.SchulzeM. B.OvervadK.et al (2008). General and Abdominal Adiposity and Risk of Death in Europe. N. Engl. J. Med.359 (20), 2105–2120. 10.1056/nejmoa0801891
51
RampalR.AlkalinA.MadzoJ.VasanthakumarA.PronierE.PatelJ.et al (2014). DNA Hydroxymethylation Profiling Reveals that WT1 Mutations Result in Loss of TET2 Function in Acute Myeloid Leukemia. Cel Rep.9 (5), 1841–1855. 10.1016/j.celrep.2014.11.004
52
RytkaJ. M.WueestS.SchoenleE. J.KonradD. (2011). The portal Theory Supported by Venous Drainage-Selective Fat Transplantation. Diabetes60 (1), 56–63. 10.2337/db10-0697
53
SaeedA.DullaartR. P. F.SchreuderT. C. M. A.BlokzijlH.FaberK. N. (2017). Disturbed Vitamin A Metabolism in Non-alcoholic Fatty Liver Disease (NAFLD). Nutrients10 (1). 10.3390/nu10010029
54
SealeP.BjorkB.YangW.KajimuraS.ChinS.KuangS.et al (2008). PRDM16 Controls a Brown Fat/skeletal Muscle Switch. Nature454 (7207), 961–967. 10.1038/nature07182
55
SealeP.ConroeH. M.EstallJ.KajimuraS.FrontiniA.IshibashiJ.et al (2011). Prdm16 Determines the Thermogenic Program of Subcutaneous white Adipose Tissue in Mice. J. Clin. Invest.121 (1), 96–105. 10.1172/jci44271
56
ShaoM.ZhangQ.TruongA.ShanB.VishvanathL.LiL.et al (2021). ZFP423 Controls EBF2 Coactivator Recruitment and PPARγ Occupancy to Determine the Thermogenic Plasticity of Adipocytes. Genes Dev.35 (21-22), 1461–1474. 10.1101/gad.348780.121
57
ShaoM.IshibashiJ.KusminskiC. M.WangQ. A.HeplerC.VishvanathL.et al (2016). Zfp423 Maintains White Adipocyte Identity through Suppression of the Beige Cell Thermogenic Gene Program. Cel Metab.23 (6), 1167–1184. 10.1016/j.cmet.2016.04.023
58
ShimobayashiM.AlbertV.WoelnerhanssenB.FreiI. C.WeissenbergerD.Meyer-GerspachA. C.et al (2018). Insulin Resistance Causes Inflammation in Adipose Tissue. J. Clin. Invest.128 (4), 1538–1550. 10.1172/jci96139
59
SidossisL. S.PorterC.SarafM. K.BørsheimE.RadhakrishnanR. S.ChaoT.et al (2015). Browning of Subcutaneous White Adipose Tissue in Humans after Severe Adrenergic Stress. Cel Metab.22 (2), 219–227. 10.1016/j.cmet.2015.06.022
60
Silveira RossiJ. L.BarbalhoS. M.Reverete de AraujoR.BecharaM. D.SloanK. P.SloanL. A. (2021). Metabolic Syndrome and Cardiovascular Diseases: Going beyond Traditional Risk Factors. Diabetes Metab. Res. Rev., e3502. 10.1002/dmrr.3502
61
StefanN. (2020). Causes, Consequences, and Treatment of Metabolically Unhealthy Fat Distribution. Lancet Diabetes Endocrinol.8 (7), 616–627. 10.1016/s2213-8587(20)30110-8
62
TanH. Y. A.SimM. F. M.TanS.-X.NgY.GanS. Y.LiH.et al (2021). HOXC10 Suppresses Browning to Maintain White Adipocyte Identity. Diabetes70 (8), 1654–1663. 10.2337/db21-0114
63
TangX.MiaoY.LuoY.SriramK.QiZ.LinF.-M.et al (2020). Suppression of Endothelial AGO1 Promotes Adipose Tissue Browning and Improves Metabolic Dysfunction. Circulation142 (4), 365–379. 10.1161/circulationaha.119.041231
64
ToskaE.RobertsS. G. E. (2014). Mechanisms of Transcriptional Regulation by WT1 (Wilms' Tumour 1). Biochem. J.461 (1), 15–32. 10.1042/bj20131587
65
TranT. T.YamamotoY.GestaS.KahnC. R. (2008). Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism. Cel Metab.7 (5), 410–420. 10.1016/j.cmet.2008.04.004
66
Van NguyenT.-T.VuV. V.PhamP. V. (2020). Transcriptional Factors of Thermogenic Adipocyte Development and Generation of Brown and Beige Adipocytes from Stem Cells. Stem Cel Rev Rep16 (5), 876–892. 10.1007/s12015-020-10013-w
67
VijayJ.GauthierM.-F.BiswellR. L.LouiselleD. A.JohnstonJ. J.CheungW. A.et al (2020). Single-cell Analysis of Human Adipose Tissue Identifies Depot- and Disease-specific Cell Types. Nat. Metab.2 (1), 97–109. 10.1038/s42255-019-0152-6
68
VishvanathL.GuptaR. K. (2019). Contribution of Adipogenesis to Healthy Adipose Tissue Expansion in Obesity. J. Clin. Invest.129 (10), 4022–4031. 10.1172/jci129191
69
VitaliA.MuranoI.ZingarettiM. C.FrontiniA.RicquierD.CintiS. (2012). The Adipose Organ of Obesity-Prone C57BL/6J Mice Is Composed of Mixed white and Brown Adipocytes. J. Lipid Res.53 (4), 619–629. 10.1194/jlr.m018846
70
WagnerK.-D.WagnerN.VidalV. P. I.SchleyG.WilhelmD.SchedlA.et al (2002). The Wilms' Tumor geneWt1is Required for normal Development of the Retina. Embo j21 (6), 1398–1405. 10.1093/emboj/21.6.1398
71
WagnerN.WagnerK.-D.HammesA.KirschnerK. M.VidalV. P.SchedlA.et al (2005). A Splice Variant of the Wilms' Tumour suppressorWt1is Required for normal Development of the Olfactory System. Development132 (6), 1327–1336. 10.1242/dev.01682
72
WajchenbergB. L. (2000). Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome. Endocr. Rev.21 (6), 697–738. 10.1210/edrv.21.6.0415
73
WangC. H.WeiY. H. (2021). Therapeutic Perspectives of Thermogenic Adipocytes in Obesity and Related Complications. Int. J. Mol. Sci.22 (13), 7117. 10.3390/ijms22137177
74
WangY.XiaoM.ChenX.ChenL.XuY.LvL.et al (2015). WT1 Recruits TET2 to Regulate its Target Gene Expression and Suppress Leukemia Cell Proliferation. Mol. Cel57 (4), 662–673. 10.1016/j.molcel.2014.12.023
75
WeiL.SurmaM.YangY.TerseyS.ShiJ. (2020). ROCK2 Inhibition Enhances the Thermogenic Program in white and Brown Fat Tissue in Mice. FASEB j.34 (1), 474–493. 10.1096/fj.201901174rr
76
WestcottG. P.EmontM. P.LiJ.JacobsC.TsaiL.RosenE. D. (2021). Mesothelial Cells Are Not a Source of Adipocytes in Mice. Cel Rep.36 (2), 109388. 10.1016/j.celrep.2021.109388
77
WilmT. P.TantonH.MutterF.FoisorV.MiddlehurstB.WardK.et al (2021). Restricted Differentiative Capacity of Wt1-Expressing Peritoneal Mesothelium in Postnatal and Adult Mice. Sci. Rep.11 (1), 15940. 10.1038/s41598-021-95380-1
78
YangL.WangX.GuoH.ZhangW.WangW.MaH. (2019). Whole Transcriptome Analysis of Obese Adipose Tissue Suggests u001kfc.1 as a Potential Regulator to Glucose Homeostasis. Front. Genet.10, 1133. 10.3389/fgene.2019.01133
79
ZiouzenkovaO.OrasanuG.SharlachM.AkiyamaT. E.BergerJ. P.ViereckJ.et al (2007). Retinaldehyde Represses Adipogenesis and Diet-Induced Obesity. Nat. Med.13 (6), 695–702. 10.1038/nm1587
80
ZuriagaM. A.FusterJ. J.GokceN.WalshK. (2017). Humans and Mice Display Opposing Patterns of "Browning" Gene Expression in Visceral and Subcutaneous White Adipose Tissue Depots. Front. Cardiovasc. Med.4, 27. 10.3389/fcvm.2017.00027
Summary
Keywords
white adipocyte, brown adipocyte differentiation, thermogenesis, uncoupling protein (UCP), WAT browning
Citation
Kirschner KM and Scholz H (2022) WT1 in Adipose Tissue: From Development to Adult Physiology. Front. Cell Dev. Biol. 10:854120. doi: 10.3389/fcell.2022.854120
Received
13 January 2022
Accepted
28 February 2022
Published
16 March 2022
Volume
10 - 2022
Edited by
You-Ying Chau, University of Edinburgh, United Kingdom
Reviewed by
Josep Villena, Vall d'Hebron Research Institute (VHIR), Spain
Martin Gericke, University Hospital Leipzig, Germany
Updates
Copyright
© 2022 Kirschner and Scholz.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Holger Scholz, holger.scholz@charite.de
This article was submitted to Signaling, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.